Is atrial fibrillation (AF) management as simple as "ABC," or does it require a broader framework such as "SOS" or "CARE"? Contemporary AF care emphasizes an integrated approach focused on stroke prevention, symptom management, and optimization of cardiovascular risk factors and comorbidities. The AFFIRMO trial…
The SINGLE-AF study evaluated whether direct oral anticoagulant (DOAC) therapy improves outcomes in patients with atrial fibrillation (AFib) who are at intermediate risk of stroke. The primary goal was to determine the net clinical benefit of anticoagulation compared with no anticoagulant therapy. The findings support…
Remote Exercise SWEDEHEART was designed to address persistently low participation in traditional cardiac rehabilitation following myocardial infarction. By delivering exercise-based rehabilitation remotely, the study aims to make recovery programs more accessible and convenient for patients. Unlike prior…
The TRANQUILITY trial was designed to evaluate whether pacibekitug can reduce interleukin-6 (IL-6)-driven inflammation, a key inflammatory pathway increasingly linked to cardiovascular risk. Treatment with pacibekitug demonstrated favorable effects on inflammatory and cardiovascular risk biomarkers, supporting IL-6…
The CorCal Outcomes study showed that using coronary artery calcium (CAC) scoring to guide statin therapy for the primary prevention of atherosclerotic cardiovascular disease (ASCVD) was as effective as the Pooled Cohort Equations (PCE) in preventing major adverse cardiovascular (CV) events. CAC-guided treatment…
Among patients with symptomatic nonobstructive hypertrophic cardiomyopathy (HCM), treatment with aficamten resulted in significantly greater improvements in exercise capacity and quality of life compared with placebo over 36 weeks. The ACACIA-HCM findings offer promising news for patients and clinicians managing this…
The PRESC1SE-MI trial evaluated whether an accelerated diagnostic pathway for suspected myocardial infarction could improve Emergency Department efficiency without compromising safety. Compared with standard care, the accelerated strategy demonstrated similar safety but did not reduce Emergency Department length of…
As TAVI expands to younger and healthier patients, valve durability has become an increasingly important consideration. However, the optimal antithrombotic strategy to support long-term valve function remains unclear. This trial compared antiplatelet monotherapy with NOAC monotherapy to help address this unmet need…
Catheter ablation is frequently performed to improve quality of life in patients with atrial fibrillation (AF). This randomized multicenter trial compared catheter ablation with a sham procedure to assess the true effect of the intervention on AF-related quality of life. In this episode, Clyde W. Yancy, MD, MACC and…
The FUND-HF trial found that financial support provided soon after hospitalization is a practical strategy for improving medication adherence among economically vulnerable patients with heart failure and reduced ejection fraction. These results lay the groundwork for future trials designed to examine the durability of…
The future of cardiovascular health depends on prevention that begins early in life. This episode reviews strategies for recognizing cardiovascular risk at an early stage and implementing interventions that can alter the trajectory of atherosclerotic cardiovascular disease before complications occur. In this…
Cardiovascular protection during cancer treatment is critical to help prevent complications such as heart failure. Patients should be educated on risk factors, symptom awareness, and heart-healthy behaviors. Oncologists should incorporate cardiovascular risk assessment and surveillance into treatment planning, while…
We use cookies to run this site. Analytics cookies, which show us how it's used, stay off unless you accept them. Change your mind any time with the cookie button at the bottom right. How we use cookies
Apple Podcasts
Spotify
Website